CClinicalTrials.gg
Status unknownNCT03408522TEAMS2Updated Jan 16, 2019

Troponin Elevation After Major Noncardiac Surgery 2

An observational study in Perioperative Myocardial Infarction, Disability and Perioperative/Postoperative Complications, sponsored by UMC Utrecht. Status unknown at 3 sites in 2 countries. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2019-01-16.

Sponsored by UMC Utrecht · Observational

The sponsor has not verified this record recently (last verified Jan 2019), so the status shown — last known as Recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,000
Ages
60 Years and older
Sex
All
01

Study summary

Major adverse cardiac events (MACE) are a leading cause of mortality in patients undergoing noncardiac surgery. Patients with perioperative myocardial injury (PMI), defined as either myocardial infarction and lower elevations in cardiac troponin, are also at substantially increased risk of additional cardiac and noncardiac complications. Accordingly, it is plausible to assume that PMI negatively affects quality of life in terms of disability. The aim of this study is to investigate and compare the independent prognostic effects of the different PMI phenotypes (myocardial infarction and non-infarct troponin elevations) and noncardiac complications on disability in patients undergoing elective noncardiac surgery.

02

Conditions studied

  • Perioperative Myocardial Infarction
  • Disability
  • Perioperative/Postoperative Complications
03

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients aged 60 years or older, undergoing major elective non-cardiac surgery under general or spinal anesthesia with an expected hospital admittance of at least 24 hours.

Inclusion criteria

  • ≥ 60 years old;
  • Major noncardiac surgery defined as all noncardiac surgical procedures requiring an expected hospital stay of at least 24 hours;
  • Elective surgery, defined as surgery that that has been preceded by a preoperative consultation at the anesthesia preoperative screening outpatient clinic.

Exclusion criteria

Exclusion Criteria:

  • Patients unable to fully comply to study needs (e.g. legally incapable patients or patients unable to communicate in Dutch or English).
  • Patients with an American Society of Anesthesiologists (ASA) Physical status 5
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,000 participants (estimated)
Patient registry
No
Biospecimen retention
Samples without dna
05

What researchers measure

Primary outcomes

  1. Disability

    Disability is expressed by the World Health Organization Disability Assessment Score 2.0 (WHODAS 2.0), which is based on difficulties experienced by the respondent in different functional domains including, cognition, mobility, self-care, getting along, life activities and participation during the previous 30 days. Disability is defined as a decrement in each functioning domain corresponding to score between 0% and 100%, in which no disability stands for a score of 0% and full disability represents a score of 100%, including death.

    Time frame: 6 months after surgery

Secondary outcomes

  1. Disability free survival

    Disability free survival is defined as being alive with a WHODAS 2.0 score ≤ 25% and no increase of the pre-operative score ≥ 25% at 6 months after surgery.

    Time frame: 6 months after surgery

  2. Major adverse cardiovascular event (MACE)

    MACE is defined as a composite outcome consisting of cardiovascular death, non-fatal myocardial infarction, non-fatal cardiac arrest, non-fatal ventricular fibrillation, ventricular arrhythmia with hemodynamic compromise, atrial fibrillation requiring cardioversion, pulmonary embolism, stroke

    Time frame: 1 week after surgery

  3. Noncardiac major adverse postoperative events (MAPE)

    Noncardiac MAPE is a composite outcome consisting of respiratory failure (including pneumonia and hypoxia or hypercapnia leading to ICU admission for respiratory support), sepsis, renal failure, unplanned ICU admission, unplanned medium care admission, reoperation

    Time frame: 1 week after surgery

  4. Length of hospital stay

    the number of days from the end of surgery until day of discharge

    Time frame: 1 week after surgery

  5. All-cause mortality

    Time frame: 1 week after surgery

  6. Major adverse cardiovascular event (MACE)

    Time frame: 6 months after surgery

  7. All-cause mortality

    Time frame: 6 months after surgery

06

Study locations

2 of 3 sites recruiting
  • Toronto General Hospital
    Toronto, Ontario M5G 2C4, Canada
    • W. Scott Beattie, MD PhD FRCPC · Contact
    Recruiting
  • Toronto Western Hospital
    Toronto, Ontario M5T 2S8, Canada
    • W. Scott Beattie, MD PhD FRCPC · Contact
    Not yet recruiting
  • UMC Utrecht
    Utrecht, Netherlands
    • Wilton A van Klei, MD, PhD · Contact
    Recruiting
07

References and documents

Study documents

  • Protocol and statistical analysis plan · Nov 7, 2017

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

08

Registry details

Key details

Study ID
NCT03408522
Lead sponsor
UMC Utrecht
Collaborators
University Health Network, Toronto
Responsible party
Wilton A van Klei (Prof. dr., UMC Utrecht) — Principal investigator
First posted
Jan 24, 2018
Start date
Jan 29, 2018
Primary completion
Jun 30, 2019 (estimated)
Completion
Dec 31, 2019 (estimated)
Last update
Jan 16, 2019

Study contacts

Wilton A van Klei, MD, PhD
Contact
w.a.vanklei@umcutrecht.nl
+3188 75 59475
Lisette M Vernooij, Msc
Contact
l.m.vernooij@umcutrecht.nl
Wilton A van Klei, MD PhD
principal investigator · prof. dr.
W. Scott Beattie, MD PhD FRCPC
principal investigator · prof. dr.

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion